Artificial selection

Find out where this artificial pancreas pioneer envisions the development of medical technologies

Frank Doyle – a prolific inventor of medical devices and director of the Harvard School of Engineering – will discuss the future of medical technology development during DeviceTalks BostonMay 10-11, 2022.

A pioneer in the development of artificial pancreas technology to treat diabetes, Doyle will share his insights into the future of medical device development, including the growing role of robotics and artificial intelligence.

(Register today!)

Doyle is Dean of the Harvard John A. Paulson School of Engineering and Applied Sciences. His success earned him election to the National Academy of Engineering last year (and the National Academies of Medicine and Inventors before that).

Doyle will address several critical areas during his keynote presentation at DeviceTalks Boston including:

  • What lessons has he learned from the many years of developing the complex systems and algorithms of an artificial pancreas and providing the support needed to bring it to market.
  • How, in his role as Dean of the Harvard Paulson School of Engineering and Applied Sciences (SEAS), he is working to solidify SEAS’ position as an industry partner and developer of the next generation of innovators.
  • Where he sees medical device innovation benefiting from increased cooperation between engineering, business and medical schools as well as hospitals, foundations and government.
  • What are the expanded capabilities of Harvard Paulson’s new 500,000 square foot Science and Engineering Center – which opened in 2020 (and is home to the Chan Zuckerberg Initiative’s (CZI) Neuroscience AI Program of 500 millions of dollars.)
  • What the medical device industry can learn and teach technology industry leaders.

Doyle will be interviewed by Peter Stebbins, a medical technology industry leader and former head of business development at Johnson & Johnson.

Questions from the audience will be encouraged in this extensive discussion.

Register now to be part of our return to Boston.